# TRPV2 Agonists in the Fontan Circulation

> **NCT03965351** · PHASE4 · COMPLETED · sponsor: **Children's Hospital Medical Center, Cincinnati** · enrollment: 8 (actual)

## Conditions studied

- Fontan

## Interventions

- **DRUG:** Probenecid
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03965351
- **Lead sponsor:** Children's Hospital Medical Center, Cincinnati
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-21
- **Primary completion:** 2020-06-30
- **Final completion:** 2020-12-31
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2021-07-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03965351

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03965351, "TRPV2 Agonists in the Fontan Circulation". Retrieved via MORVS 2026-10-15 from https://api.morvs.ai/clinical/NCT03965351. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*